Status:
COMPLETED
Paracetamol Metabolism in Post Operative Conditions
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Aortic Surgery and Treatment Post Operative With Paracetamol During 4 Days
Eligibility:
All Genders
18+ years
Brief Summary
Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)
Detailed Description
D-15 to D0: selection * patient information and non-opposition obtained * inclusion and non inclusion criteria check * clinical exam D-1 to D0 : 24 hours diuresis D0 : operation day Before anesthe...
Eligibility Criteria
Inclusion
- aortic surgery
- treatment with intraveinous paracetamol (4 grammes daily during 4 days)
- patient agrees to participate
Exclusion
- \- patient disagrees
- paracetamol contra-indication
- paracetamol intake 5 days before surgery
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01152502
Start Date
June 1 2008
End Date
June 1 2010
Last Update
June 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003